Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 17-22

  Kasai, Takashi ^a,c   Tokuda, Takahiko ^a   Taylor, Mark ^c   Kondo, Masaki ^a   Mann, David M A ^b   Foulds, Penelope G ^c   Nakagawa, Masanori ^a   Allsop, David ^c  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Amyloid ; ELISA; Heterophilic antibody; Matched serum and CSF; Oligomer

Indexed keywords

AMYLOID BETA PROTEIN; CARRIER PROTEIN; HETEROPHILE ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BAN50; OLIGOMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

AMYLOID-Β; ELISA; HETEROPHILIC ANTIBODY; MATCHED SERUM AND CSF; OLIGOMER;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84882262363     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.029     Document Type: Article

References (15)

1. Allsop D., Landon M., Kidd M. The isolation and amino acid composition of senile plaque core protein. Brain Res. 1983, 259:348-352.
2. Biere A.L., Ostaszewski B., Stimson E.R., Hyman B.T., Maggio J.E., Selkoe D.J. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J. Biol. Chem. 1996, 271:32916-32922.
3. Cramer P.E., Cirrito J.R., Wesson D.W., Lee C.Y., Karlo J.C., Zinn A.E., Casali B.T., Restivo J.L., Goebel W.D., James M.J., Brunden K.R., Wilson D.A., Landreth G.E. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 2012, 335:1503-1506.
4. Csako G., Weintraub B.D., Zweig M.H. The potency of immunoglobulin G fragments for inhibition of interference caused by anti-immunoglobulin antibodies in a monoclonal immunoradiometric assay for thyrotropin. Clin. Chem. 1988, 34:1481-1483.
5. Fukumoto H., Tokuda T., Kasai T., Ishigami N., Hidaka H., Kondo M., Allsop D., Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J. 2010, 24:2716-2726.
6. Gao C.M., Yam A.Y., Wang X., Magdangal E., Salisbury C., Peretz D., Zuckermann R.N., Connolly M.D., Hansson O., Minthon L., Zetterberg H., Blennow K., Fedynyshyn J.P., Allauzen S. Abeta40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease. PLoS ONE 2010, 5:e15725.
7. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 1993, 16:460-465.
8. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
9. Kasai T., Tokuda T., Taylar M., Nakagawa M., Allsop D. Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers. Biochem. Biophys. Res. Commun. 2012, 422:375-380.
10. Le Bastard N., Aerts L., Leurs J., Blomme W., De Deyn P.P., Engelborghs S. No correlation between time-linked plasma and CSF Abeta levels. Neurochem. Int. 2009, 55:820-825.
11. Santos A.N., Simm A., Holthoff V., Boehm G. A method for the detection of amyloid-beta1-40, amyloid-beta1-42 and amyloid-beta oligomers in blood using magnetic beads in combination with flow cytometry and its application in the diagnostics of Alzheimer's disease. J. Alzheimers Dis. 2008, 14:127-131.
12. Schupf N., Tang M.X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14052-14057.
13. Sehlin D., Sollvander S., Paulie S., Brundin R., Ingelsson M., Lannfelt L., Pettersson F.E., Englund H. Interference from heterophilic antibodies in amyloid-beta oligomer ELISAs. J. Alzheimers Dis. 2010, 21:1295-1301.
14. Ueno M., Nakagawa T., Wu B., Onodera M., Huang C.L., Kusaka T., Araki N., Sakamoto H. Transporters in the brain endothelial barrier. Curr. Med. Chem. 2010, 17:1125-1138.
15. Xia W., Yang T., Shankar G., Smith I.M., Shen Y., Walsh D.M., Selkoe D.J. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch. Neurol. 2009, 66:190-199.